Veno‐arteriovenous (V‐AV) ECMO configuration: A single‐center experience.

Background: With increasing extracorporeal membrane oxygenation (ECMO) utilization over the last decade, clinicians have developed "hybrid" configurations to meet complex perfusion requirements. In the setting of differential hypoxemia, a veno‐arteriovenous (V‐AV) configuration provides oxygenated cardiac preload and hemodynamic support to satisfy physiologic demands. We aim to further characterize the patient population, indications, and outcomes associated with this hybrid configuration. Methods: We retrospectively reviewed all adult patients placed on V‐AV ECMO at our institution from June 2016 to December 2019. Through a review of the electronic medical records, data describing demographic features, comorbidities, and ECMO‐specific information were analyzed systematically. Results: 14 patients were placed on V‐AV ECMO during the study period. Our cohort was 79% male with a median age of 54 and BMI of 30.3. These patients had a median SOFA‐0 score of 15 and SAVE score of ‐12. Patients were treated with ECMO support for a median of 144.1 (IQR 98.5 – 183.1) hours, consisting of 0.2 (IQR 0 – 17.7) hours of VA and 92.4 (IQR 53.7 – 115.1) hours of V‐AV followed by 67.4 (IQR 20.3 – 96.6) hours of VV support. Of these 14 patients, 11 survived to decannulation (79%) and 9 survived to hospital discharge (64%). Conclusion: ECMO patients with recovering left ventricular function and persistent gas exchange abnormalities are at risk for developing differential hypoxemia. We describe an approach to utilizing V‐AV configuration when the likelihood of differential hypoxemia is extremely high, with a survival rate that compares favorably to Extracorporeal Life Support Organization statistics and published case series. [ABSTRACT FROM AUTHOR]